![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/08/Cytiva-Developing-scalable-AAV-processes-from-start-to-finish-pdf.jpg)
Developing scalable AAV processes from start to finish
By Cytiva
There are essential challenges to overcome in adeno-associated virus (AAV) production. Thanks to years of accumulated expertise in the field, Cytiva’s new eBook on the topic covers essential aspects of AAV process development, from choosing suitable host cells and optimising transfection conditions to addressing the complexities of scalable production and efficient virus purification. Offering valuable strategies for improving both upstream and downstream processes, it’s an essential read for firms involved in development and manufacture of gene therapies. Fill in your details now.
![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/08/Cytiva-Developing-scalable-AAV-processes-from-start-to-finish-pdf.jpg)